Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

Cited by (504)

Items 101–200 of 504

  1. Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity
    Vicky Wang-Wei Tsai, H P Zhang, Rakesh Manandhar, Ka Ki Michelle Lee-Ng, Hélène Lebhar, Christopher Peter Marquis, Yasmin Husaini, Amanda Sainsbury, David Alexander Brown, Samuel N. Breit · 2017 · International Journal of Obesity
  2. Elevated levels of MIC‐1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome
    Sophie Shnaper, Isabelle Desbaillets, David Alexander Brown, Anastasia Murat, Eugenia Migliavacca, Myriam Schluep, Sandrine Ostermann, Marie‐France Hamou, Roger Stupp, Samuel N. Breit et al. · 2009 · International Journal of Cancer
  3. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: A potential marker of erosive joint destruction
    David Alexander Brown, John J. Moore, Heiko Johnen, Tom J. M. Smeets, Asne R. Bauskin, Támara Kuffner, Helen Weedon, Samuel T. Milliken, Paul Peter Tak, Malcolm Smith et al. · 2007 · Arthritis & Rheumatism
  4. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts
    Ramirez, Jean‐Marie, Schaad, Olivier, Durual, Stephane, Cossali, Dominique, Docquier, Mylène, Beris, Photis, Descombes, Patrick, Matthes, Thomas · 2009 · British Journal of Haematology
  5. Selective binding and enrichment for low‐molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles
    Rosa Terracciano, Marco Gaspari, Flaviano Testa, Luigi Pasqua, Pierosandro Tagliaferri, Mark Ming‐Cheng Cheng, A. Jasper Nijdam, Emanuel F. Petricoin, Lance A. Liotta, Giovanni Cuda et al. · 2006 · PROTEOMICS
  6. Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration
    Maria Kalli, Panagiotis Papageorgis, Vasiliki Gkretsi, Triantafyllos Stylianopoulos · 2018 · Annals of Biomedical Engineering
  7. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome—An Observational Pilot Study
    Quirin Notz, Marc Schmalzing, Florian Wedekink, Tobias Schlesinger, Michael Gernert, Johannes Herrmann, Lena Sorger, Dirk Weismann, Benedikt Schmid, Magdalena Sitter et al. · 2020 · Frontiers in Immunology
  8. Sensitive and simultaneous detection of multi-index lung cancer biomarkers by an NIR-Ⅱ fluorescence lateral-flow immunoassay platform
    Lijiao Ao, Tao Liao, Liang Huang, Shan Lin, Kui Xu, Jiangtao Ma, Shaorong Qiu, Xiangyu Wang, Qiqing Zhang · 2022 · Chemical Engineering Journal
  9. The GDNF Family: A Role in Cancer?
    Graeme C. Fielder, Teresa Wen-Shan Yang, Mahalakshmi Razdan, Yan Li, Jun Lu, Jo Kate Perry, Peter Edward Lobie, Dong‐Xu Liu · 2017 · Neoplasia
  10. Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI
    Vicky Wang-Wei Tsai, Laurence Macia, Christine Feinle‐Bisset, Rakesh Manandhar, Arne Vernon Astrup, Anne Raben, Janne K. Lorenzen, Peter Thelin Schmidt, Fredrik E. Wiklund, Nancy L. Pedersen et al. · 2015 · PLoS ONE
  11. Serum Macrophage Inhibitory Cytokine-1 Concentrations Correlate with the Presence of Prostate Cancer Bone Metastases
    Katri S. Selander, David Alexander Brown, Guillermo Blanco Sequeiros, Mark I Hunter, Renée A. Desmond, Teija M Parpala, Juha Risteli, Samuel N. Breit, Arja Jukkola‐Vuorinen · 2007 · Cancer Epidemiology Biomarkers & Prevention
  12. The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling
    Amy A. Worth, Rosemary Shoop, Katie Tye, Claire H. Feetham, Giuseppe D’Agostino, Garron T. Dodd, Frank M. Reimann, Fiona Mary Gribble, Emily Beebe, James D. Dunbar et al. · 2020 · eLife
  13. Growth differentiation factor-15 and its role in diabetes and cardiovascular disease
    Adrian C. Eddy, Aaron J. Trask · 2020 · Cytokine & Growth Factor Reviews
  14. Gene expression changes during HPV‐mediated carcinogenesis: A comparison between an in vitro cell model and cervical cancer
    Fang Wan, Xijiang Miao, Iram Quraishi, Valerie Kennedy, Kim E. Creek, Lucia A. Pirisi · 2008 · International Journal of Cancer
  15. The Role of Inflammation in Prostate Cancer
    Karen Sandell Sfanos, Heidi Hempel, Angelo Michael De Marzo · 2014 · Advances in experimental medicine and biology
  16. GDF15 knockdown promotes erastin-induced ferroptosis by decreasing SLC7A11 expression
    Liang Chen, Linlin Qiao, Yue Bian, Xiuju Sun · 2020 · Biochemical and Biophysical Research Communications
  17. Applications of a Rat Multiple Tissue Gene Expression Data Set
    John R. Walker, Andrew I. Su, David W. Self, John B. Hogenesch, Hilmar Lapp, Rainer M. Maier, Daniël Hoyer, Graeme Bilbe · 2004 · Genome Research
  18. Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast Cancer
    Rita Nahta · 2012 · ISRN Oncology
  19. Systemic effects of mitochondrial stress
    Raz Bar‐Ziv, Theodore Bolas, Andrew G. Dillin · 2020 · EMBO Reports
  20. Targeting Obesity and Cachexia: Identification of the GFRAL Receptor–MIC-1/GDF15 Pathway
    Samuel N. Breit, Vicky Wang-Wei Tsai, David Alexander Brown · 2017 · Trends in Molecular Medicine
  21. Anorexia/cachexia of chronic diseases: a role for the TGF‐β family cytokine MIC‐1/GDF15
    Vicky Wang-Wei Tsai, Yasmin Husaini, Rakesh Manandhar, Ka Ki Michelle Lee-Ng, Hong Ping Zhang, Kate Harriott, Lele Jiang, Shu Lin, Amanda Sainsbury, David Alexander Brown et al. · 2012 · Journal of Cachexia Sarcopenia and Muscle
  22. Biomarkers of ovarian tumours
    Amy Rapkiewicz, Virginia A. Espina, Emanuel F. Petricoin, Lance A. Liotta · 2004 · European Journal of Cancer
  23. The expression landscape of cachexia‐inducing factors in human cancers
    Paula Paccielli Freire, Geysson Javier Fernández, Diogo de Moraes, Sarah Santiloni Cury, Maeli Dal‐Pai‐Silva, Patrícia P. Reis, Sílvia Regina Rogatto, Robson Francisco Carvalho · 2020 · Journal of Cachexia Sarcopenia and Muscle
  24. Protein Kinase C-dependent Regulation of NAG-1/Placental Bone Morphogenic Protein/MIC-1 Expression in LNCaP Prostate Carcinoma Cells
    Minsub Shim, Thomas E. Eling · 2005 · Journal of Biological Chemistry
  25. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer
    Lingjin Huang, Shengxi Chen, Yan Huang, Wanjun Luo, Haihe Jiang, Qinghua Hu, Pengfei Zhang, Hong Liang Yi · 2006 · Lung Cancer
  26. GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH
    Kook Hwan Kim, Myung‐Shik Lee · 2020 · Biochimica et Biophysica Acta (BBA) - General Subjects
  27. Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model
    Jung Eun Kim, Kyung Hee Koo, Yeul Hong Kim, Jeongwon Sohn, Yun Gyu Park · 2008 · Experimental & Molecular Medicine
  28. Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer
    Anne Cathrine Staff, Jone Trovik, Eriksson Ane Gerda Zahl, Elisabeth Wik, Kai Christoph Wollert, Tibor Kempf, Helga Birgitte Salvesen · 2011 · Clinical Cancer Research
  29. Characterization of Arecoline-Induced Effects on Cytotoxicity in Normal Human Gingival Fibroblasts by Global Gene Expression Profiling
    Shang‐Lun Chiang, Shih Sheng Jiang, Yi-Jou Wang, Horn-Che Chiang, Ping‐Ho Chen, Hung‐Pin Tu, Kun‐Yen Ho, Yu-Shan Tsai, I‐Shou Chang, Ying‐Chin Ko · 2007 · Toxicological Sciences
  30. Prostate‐derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor‐positive human prostate cancer cells
    Siu-Ju Chen, Dev Karan, Sonny L. Johansson, Fen‐Fen Lin, Jeffrey M. Zeckser, Ajay P. Singh, Surinder K. Batra, Ming‐Fong Lin · 2007 · The Prostate
  31. A Systematic Investigation of the Malignant Functions and Diagnostic Potential of the Cancer Secretome
    Jonathan L. Robinson, Amir Feizi, Mathias Uhlén, Jens Nielsen · 2019 · Cell Reports
  32. A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia
    Jeffrey Crawford, Roberto A. Calle, Susie M. Collins, Yan Weng, Shannon L. Lubaczewski, Clare Buckeridge, Ellen Q. Wang, Magdalena Alicja Harrington, Anil Tarachandani, Michelle I. Rossulek et al. · 2023 · Clinical Cancer Research
  33. Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics
    Da‐elene van der Merwe, Κατερίνα Οικονομοπούλου, John G. Marshall, Eleftherios P. Diamandis · 2006 · Advances in cancer research
  34. Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients
    David Turay, Salma Khan, Carlos Joel Diaz Osterman, Matthew P. Curtis, Balreet Khaira, Jonathan W. Neidigh, Saied Mirshahidi, Carlos A. Casiano, Nathan R. Wall · 2015 · Cancer Investigation
  35. Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells
    Jayashree P. Joshi, Nicole E. Brown, Samantha E. Griner, Rita Nahta · 2011 · Biochemical Pharmacology
  36. GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis
    Michael R. Preusch, Matthias Baeuerle, Claudia Albrecht, Erwin Blessing, Marc Bischof, Hugo Albert Katus, Florian Bea · 2013 · European journal of medical research
  37. Using Aptamers for Cancer Biomarker Discovery
    Yun Min Chang, Michael J. Donovan, Weihong Tan · 2013 · Journal of Nucleic Acids
  38. ALX1 Induces Snail Expression to Promote Epithelial-to-Mesenchymal Transition and Invasion of Ovarian Cancer Cells
    Hong Yuan, Hiroaki Kajiyama, Satoko Ito, Nobuhisa Yoshikawa, Toshinori Hyodo, Eri Asano, Hitoki Hasegawa, Masao Maeda, Kiyosumi Shibata, Michinari Hamaguchi et al. · 2013 · Cancer Research
  39. Aberrant Neuropeptide Y and Macrophage Inhibitory Cytokine-1 Expression Are Early Events in Prostate Cancer Development and Are Associated with Poor Prognosis
    Krishan Rasiah, James G. Kench, Margaret Gardiner‐Garden, Andrew Victor Biankin, David Golovsky, Phillip C. Brenner, Raji Kooner, Gordon O’Neill, Jennifer Turner, Warick Delprado et al. · 2006 · Cancer Epidemiology Biomarkers & Prevention
  40. Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling
    Bridgette F. Peake, Siobhan M. Eze, Lily P H Yang, Robert Craig Castellino, Rita Nahta · 2017 · Oncotarget
  41. A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer
    Shivashankar Hiriyur Nagaraj, Antônio Reverter · 2011 · BMC Systems Biology
  42. Growth/differentiation factor-15: prostate cancer suppressor or promoter?
    Petr Vaňhara, Aleš Hampl, Alois Kozubík, Karel Souček · 2012 · Prostate Cancer and Prostatic Diseases
  43. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
    Chen Li, Xiaobing Wang, José Ignacio Casal, Jingyu Wang, Peiwei Li, Wei Zhang, Enping Xu, Maode Lai, Honghe Zhang · 2016 · Journal of Cellular and Molecular Medicine
  44. Dysregulated expression of MIC-1/PDF in human prostate tumor cells
    Dev Karan, Siu-Ju Chen, Sonny L. Johansson, Ajay P. Singh, Vishwas M. Paralkar, Ming‐Fong Lin, Surinder K. Batra · 2003 · Biochemical and Biophysical Research Communications
  45. Gene Expression Profiling of Human Cancers
    Giselda Bucca, Giuseppe Carruba, Annalisa Saetta, Paula Muti, LUIGI A. M. CASTAGNETTA, Colin P. Sambrook Smith · 2004 · Annals of the New York Academy of Sciences
  46. The TGF-β Superfamily Cytokine MIC-1/GDF15: Secretory Mechanisms Facilitate Creation of Latent Stromal Stores
    Asne R. Bauskin, Lele Jiang, Xiaohe Luo, Liyun Wu, David Alexander Brown, Samuel N. Breit · 2010 · Journal of Interferon & Cytokine Research
  47. YAP promotes breast cancer metastasis by repressing growth differentiation factor-15
    Ting Wang, Beibei Mao, Chi Cheng, Zhuangzhi Zou, Junling Gao, Yanglu Yang, Tong Lei, Xiaolong Qi, Zengqiang Yuan, Wentong Xu et al. · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  48. A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy
    Yingye Zheng, Dionyssios Katsaros, Shannon J.C. Shan, Irene A. Rigault de la Longrais, Mauro Porpiglia, Andreas Scorilas, Nam W. Kim, Robert L. Wolfert, Iris Simón, Lin Li et al. · 2007 · Clinical Cancer Research
  49. Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion
    Samantha E. Griner, Jayashree P. Joshi, Rita Nahta · 2012 · Biochemical Pharmacology
  50. Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer?
    David Alexander Brown, Kenneth W. Hance, Connie Jo Rogers, Leah B. Sansbury, Paul S. Albert, Gwen A Murphy, Adeyinka O. Laiyemo, Zhuoqiao Wang, Amanda Jane Cross, Arthur G. Schatzkin et al. · 2012 · Cancer Epidemiology Biomarkers & Prevention
  51. Histological coherent Raman imaging: a prognostic review
    Marcus T. Cicerone, Charles H. Camp · 2017 · The Analyst
  52. Identification of diagnostic serum protein profiles of glioblastoma patients
    Anja Elstner, Florian Stockhammer, Trong-Nghia Nguyen-Dobinsky, Quang Long Nguyen, Ingo Pilgermann, Amanjit Gill, Anke Guhr, Tingguo Zhang, Kajetan von Eckardstein, Thomas Picht et al. · 2010 · Journal of Neuro-Oncology
  53. Computational prediction of human proteins that can be secreted into the bloodstream
    Juan Cui, Qi Liu, David Puett, Ying Xu · 2008 · Bioinformatics
  54. Anti-Inflammatory Agent Indomethacin Reduces Invasion and Alters Metabolism in a Human Breast Cancer Cell Line
    Ellen Ackerstaff, Barjor Gimi, Dmitri Artemov, Zaver M. Bhujwalla · 2007 · Neoplasia
  55. Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer
    Carla A. Borgoño, Tadaaki Kishi, Andreas Scorilas, Nadia Harbeck, Julia Dorn, Barbara Schmalfeldt, Manfred Schmitt, Eleftherios P. Diamandis · 2006 · Clinical Cancer Research
  56. Overview of growth differentiation factor 15 (GDF15) in metabolic diseases
    Jian Li, Xiangjun Hu, Zichuan Xie, Jiajin Li, Chen Lu Huang, Yan Huang · 2024 · Biomedicine & Pharmacotherapy
  57. Expression of macrophage inhibitory cytokine‐1 in prostate cancer bone metastases induces osteoclast activation and weight loss
    Savita Wakchoure, Telisha Millender Swain, Teuvo A. Hentunen, Asne R. Bauskin, David Alexander Brown, Samuel N. Breit, Katri S. Vuopala, Kevin W. Harris, Katri S. Selander · 2009 · The Prostate
  58. Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer
    Nicole Blanchette-Farra, Daniel Kita, Anna Konstorum, Lia Tesfay, David J. Lemler, Poornima Hegde, Kevin P. Claffey, Frank M. Torti, Suzy V. Torti · 2018 · Oncogene
  59. Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury
    Jing Liu, Sanjeev Kumar, Andreas Heinzel, Michael Gao, Jinjin Guo, Gregory F. Alvarado, Roman Reindl‐Schwaighofer, A. Michaela Krautzberger, Pietro E. Cippà, Jill A. McMahon et al. · 2020 · Journal of the American Society of Nephrology
  60. Identification of Lung Cancer Patients by Serum Protein Profiling Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
    Ke-qi Han, Guang Huang, Chunfang Gao, Xiu-li Wang, Bo Ma, Liang-qi Sun, Zhijie Wei · 2008 · American Journal of Clinical Oncology
  61. Placenta: an old organ with new functions
    Sara Khorami-Sarvestani, Negar Vanaki, Sorour Shojaeian, Kayhan Zarnani, Allan Stensballe, Mahmood Jeddi‐Tehrani, Amir‐Hassan Zarnani · 2024 · Frontiers in Immunology
  62. Development and Use of Biomarkers in Oncology Drug Development
    Eugenia Floyd, Teresa M. McShane · 2004 · Toxicologic Pathology
  63. Bioinformatics Strategies for Translating Genome‐Wide Expression Analyses into Clinically Useful Cancer Markers
    Daniel R. Rhodes, Arul M. Chinnaiyan · 2004 · Annals of the New York Academy of Sciences
  64. Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways
    Young‐June Jin, Jeong-Hyung Lee, Young-Myeong Kim, Goo Taeg Oh, Hansoo Lee · 2012 · Cellular Signalling
  65. Genetic variability in inflammation pathways and prostate cancer risk
    Jielin Sun, Aubrey R. Turner, Jianfeng Xu, Henrik Grönberg, William B. Isaacs · 2007 · Urologic Oncology Seminars and Original Investigations
  66. Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1
    Yingjuan Qian, Yong-Sam Jung, Xinbin Chen · 2012 · Proceedings of the National Academy of Sciences
  67. Elevated GDF-15 contributes to pulmonary inflammation upon cigarette smoke exposure
    F.M. Verhamme, Leen Seys, Elise G De Smet, Sharen Provoost, Wim Janssens, Dirk Sw Elewaut, Guy Joos, Guy Brusselle, Ken R. Bracke · 2017 · Mucosal Immunology
  68. The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7
    Ruth L. Vinall, Clifford G. Tepper, X-B Shi, L A Xue, Regina F. Gandour‐Edwards, Ralph Devere White · 2006 · Oncogene
  69. The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts
    Anne-France Le Rolle, Thang Kien Chiu, Michael G. Fara, Jinru Shia, Zhaoshi Zeng, Martin R. Weiser, Philip B. Paty, Vi Kien Chiu · 2015 · Journal of Translational Medicine
  70. P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer
    Solomon-Miles Donnelly, E. Paplomata, B.M. Peake, E. Sanabria, Zhuo Chen, Rita Nahta · 2013 · Current Medicinal Chemistry
  71. Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis
    Jojo Reyes, George S. Yap · 2023 · The Journal of Immunology
  72. Reg IV: A Promising Marker of Hormone Refractory Metastatic Prostate Cancer
    Zhennan Gu, Mark A. Rubin, Yu Yang, Samuel E. DePrimo, Hongjuan Zhao, Steve Horvath, James D. Brooks, Massimo F. Loda, Robert Evan Reiter · 2005 · Clinical Cancer Research
  73. An autocrine/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells
    Asako Sasahara, Kana Tominaga, Tatsunori Nishimura, Masao Yano, Etsuko Kiyokawa, Miki Noguchi, Masakuni Noguchi, Hajime Kanauchi, Toshihisa Ogawa, Hiroshi Minato et al. · 2017 · Oncotarget
  74. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens
    Vanessa C. Thompson, Tanis G.W. Morris, Dawn R. Cochrane, John Cavanagh, Latif A. Wafa, Tatyana Hamilton, Shunyou Wang, Ladan Fazli, Martin Edwin Gleave, Colleen C. Nelson · 2006 · The Prostate
  75. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma
    Eik Schiegnitz, Peer Wolfgang Kämmerer, Felix P. Koch, Maximilian Krüger, Manfred Berres, Bilal Al‐Nawas · 2012 · Oral Oncology
  76. Growth differentiation factor 15 as a potential therapeutic for treating obesity
    Clarence Hale, Murielle M. Véniant · 2020 · Molecular Metabolism
  77. Cancer-Associated Muscle Wasting—Candidate Mechanisms and Molecular Pathways
    Victoria Armstrong, Liam W. Fitzgerald, Oliver F. Bathe · 2020 · International Journal of Molecular Sciences
  78. Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development
    Sung Jin Huh, Chin-Ying Chung, Arati K. Sharma, Gavin P. Robertson · 2010 · American Journal Of Pathology
  79. Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery
    Ioannis Prassas, Caitlin C Chrystoja, Shalini Makawita, Eleftherios P. Diamandis · 2012 · BMC Medicine
  80. Growth Differentiation Factor-15 (GDF-15) Is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients
    Toshiaki Nakajima, Ikuko Shibasaki, Tatsuya Sawaguchi, Akiko Haruyama, Hiroyuki Kaneda, Takafumi Nakajima, Takaaki Hasegawa, Takuo Arikawa, Syotaro Obi, Masashi Sakuma et al. · 2019 · Journal of Clinical Medicine
  81. Role of the mitochondrial stress response in human cancer progression
    Sheng‐Fan Wang, Shiuan Chen, Ling‐Ming Tseng, Hsin‐Chen Lee · 2020 · Experimental Biology and Medicine
  82. An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma
    Ivo M. Meinhold-Heerlein, Dirk Bauerschlag, Yingyao Zhou, Lisa M. Sapinoso, Keith A. Ching, Henry F. Frierson, Karen Bräutigam, Jalid Sehouli, Elmar Stickeler, Dominique Könsgen et al. · 2007 · Clinical Cancer Research
  83. Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma
    Meeta P. Pradhan, Akshay Desai, Mathew J. Palakal · 2013 · BMC Systems Biology
  84. Anorexia‐cachexia syndrome in hepatoma tumour‐bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC‐1/GDF15
    Tito Borner, Myrtha Arnold, Johan Ruud, Samuel N. Breit, Wolfgang Langhans, Thomas A. Lutz, Anders G. Blomqvist, Thomas Riediger · 2016 · Journal of Cachexia Sarcopenia and Muscle
  85. Differential Secreted Proteome Approach in Murine Model for Candidate Biomarker Discovery in Colon Cancer
    Kannan Rangiah, Montri Tippornwong, Vineet Sangar, David Austin, Marie-Pier Tétreault, Anil K. Rustgi, Ian A. Blair, Kenneth H. Yu · 2009 · Journal of Proteome Research
  86. DNA methylation‐mediated silencing of nonsteroidal anti‐inflammatory drug‐activated gene (NAG‐1/GDF15) in glioma cell lines
    Mitsutoshi Kadowaki, Hiroki Yoshioka, Hideki Kamitani, Takashi Watanabe, Paul A. Wade, Thomas E. Eling · 2011 · International Journal of Cancer
  87. Circulating Levels of GDF15, MMP7 and miR-200c as a Poor Prognostic Signature in Gastric Cancer
    Moisés Blanco, Nuria Tarrío, Margarita Reboredo, Mar Haz‐Conde, Jorge García, María Quindós, Angélica Figueroa, Luis Miguel Antón-Aparicio, Lourdes Calvo, Manuel Valladares‐Ayerbes · 2014 · Future Oncology
  88. GDF15 Promotes Cell Growth, Migration, and Invasion in Gastric Cancer by Inducing STAT3 Activation
    Mina Joo, Dong‐Hyun Kim, Myung-Won Lee, Hyo Jin Lee, Jin‐Man Kim · 2023 · International Journal of Molecular Sciences
  89. State of the Art in Tumor Antigen and Biomarker Discovery
    Klervi Even-Desrumeaux, Daniel Baty, Patrick Chames · 2011 · Cancers
  90. Circulating growth/differentiation factor 15 is associated with human CD56bright natural killer cell dysfunction and nosocomial infection in severe systemic inflammation
    Holger Kleinertz, Monika Hepner-Schefczyk, Sabrina Ehnert, Maren Claus, Rebecca Halbgebauer, Lea Katharina Boller, Markus Stefan Huber-Lang, Paolo Cinelli, Carsten J. Kirschning, Sascha Flohé et al. · 2019 · EBioMedicine
  91. Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
    Ke‐Hung Tsui, Ying‐Ling Chang, Tsui‐Hsia Feng, Li‐Chuan Chung, Tzu-Yi Lee, Phei‐Lang Chang, Horng‐Heng Juang · 2012 · Journal of Molecular Endocrinology
  92. Circulating Growth Factor Levels Are Associated with Tumorigenesis in Neurofibromatosis Type 1
    George A. Mashour, Pablo Hernáiz Driever, Melanie Hartmann, Stephanie Nicole Drissel, Tingguo Zhang, Bianca Scharf, Ursula Felderhoff‐Müser, Sadatoshi Sakuma, Reinhard Edgar Friedrich, Robert L. Martuza et al. · 2004 · Clinical Cancer Research
  93. Prediction of Body Fluids where Proteins are Secreted into Based on Protein Interaction Network
    Le‐Le Hu, Tao Huang, Yu‐Dong Cai, Kuo‐Chen Chou · 2011 · PLoS ONE
  94. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody‐based therapy
    Xiaobing Wang, Xingran Jiang, Xiying Yu, Lin Wang, Shun He, Feiyue Feng, Li‐Ping Guo, Wei Bo Jiang, Shih‐Hsin Lu · 2013 · Cancer Science
  95. The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells
    Wyatt Wollmann, Mike L. Goodman, Poornima Bhat‐Nakshatri, Hiromitsu Kishimoto, Robert J. Goulet, Sanjana Mehrotra, Akira Morimiya, Sunil Badve, Harikrishna Nakshatri · 2005 · Carcinogenesis
  96. Tissue microarrays: applications in genomic research
    Aprill T. Watanabe, Robert Cornelison, Galen H. Hostetter · 2005 · Expert Review of Molecular Diagnostics
  97. A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance
    Martin A. Whiteside, Dung‐Tsa Chen, Renée A. Desmond, Sarki Abba Abdulkadir, Gary L. Johanning · 2004 · Oncogene
  98. Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer
    Richard J.E. Skipworth, D A C Deans, Benjamin H. L. Tan, Kathryn Sangster, Simon Paterson‐Brown, David Alexander Brown, M Hunter, Samuel N. Breit, J. A. Ross, Kenneth C. H. Fearon · 2010 · British Journal of Cancer
  99. Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer
    Michal Vočka, Daniël Langer, Vladimír Frýba, J Petrtýl, Tomáš Hanuš, Marta Kalousová, Tomáš Zima, Lubos B. Petruzelka · 2018 · Cancer Biomarkers
  100. Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression
    Panagiotis Mitsopoulos, Zacharias E. Suntres · 2011 · Journal of Toxicology